Establishing content validity of the oral assessment guide in children and young people.
There is a need for accurate and consistent oral assessment to measure mucosal changes and oral complications associated with cancer therapies. Mucositis is an important and common side effect of cancer therapies that merits the identification of improved health-care interventions. Developing appropriate and reliable oral assessment instruments for use with children is relevant to the evaluation of these interventions. The purpose of this study was to determine the content validity of the oral assessment guide (OAG) in children: an instrument that was designed to objectively assess the physiological changes of the oral cavity following administration of chemotherapy and radiotherapy to adults. This process is considered to be most effective when undertaken systematically. A judgement quantification process was used with health care professionals in paediatric oncology to establish content validity of items (n=9) and instrument (n=10). A revised OAG more pertinent to children and young people was produced in the light of this process.
Gibson
Faith
F
Centre for Nursing and Allied Health Professions Research, 7th Floor Old Building, Great Ormond Street Hospital for Children NHS Trust and Institute of Child Health, Great Ormond Street, London WC1N 3JH, United Kingdom. Gibsof@gosh.nhs.uk
Cargill
Jamie
J
Allison
Jenny
J
Begent
Joanna
J
Cole
Sue
S
Stone
Joanna
J
Lucas
Victoria
V
D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D003680:Deglutition Disorders / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D009059:Mouth Diseases / Q000175:diagnosis / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy*; D009909:Oral Health; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D013280:Stomatitis / Q000175:diagnosis* / Q000209:etiology; D011795:Surveys and Questionnaires; D014076:Tooth Diseases / Q000175:diagnosis / Q000209:etiology; D014832:Voice Disorders / Q000175:diagnosis / Q000209:etiology
D000970:Antineoplastic Agents